Beech leaf disease (BLD) is an emerging tree disease in the Northeast for American beech (*Fagus grandifolia*) trees in Ohio, Pennsylvania, New York and Connecticut. It was discovered first in 2012 near Lake Erie in the Cleveland Metroparks, region of Ohio ([@ref013]). The leaves that host BLD have noticeable symptoms of banded dark green to chlorotic lesions between veins that increase in intensity and nematode numbers from summer to autumn. Many American beech trees with BLD may die eventually and this loss would devastate the beech-maple forest ecosystems of the eastern USA. The etiology was not understood ([@ref009]) until recently when a nematode was demonstrated to be necessary for experimental symptom production ([@ref003]). As the disease spreads, accurate identification of nematodes in new symptomatic trees is more important than ever to delimit and potentially contain the spread of the disease and to identify the nematode in surveys outside the USA where related species may exist.

Molecular and morphological taxonomic identifications were conducted in our lab with the nematodes isolated from the lesions of the BLD leaves collected in Fall, 2017 from Perry, Lake County, Ohio, USA by an Ohio Department of Agriculture nursery inspector from ailing American beech trees *Fagus grandifolia* (Fall specimens). Their ribosomal DNA (rDNA) loci were amplified by PCR with the one primer set and an enhanced DNA polymerase system, and the resulting 3.5 kb (18 S, ITS and 28 S) rDNA amplicons were directly sequenced ([@ref004]). Morphological evaluation and an initial GenBank search revealed that this was an unknown species in the genus *Litylenchus*. Shortly after this discovery, a *Litylenchus* nematode from leaf galls of *Fagus crenata* in Japan was described as *Litylenchus crenatae* ([@ref012]), showing a few different DNA base pairs from the nematode population we sequenced. Based on these molecular, morphological and host range differences, a new subspecies *Litylenchus crenatae mccannii* was described ([@ref003]).

Special handling of nematodes in PCR reactions is needed because of potential molecular marker variation within and between individual nematodes, plus their often tiny size and chemically resistant cuticle that may create unexpected challenges. Among more than 40 *Litylenchus* specimens from the samples collected from Ohio and Pennsylvania during the summer of 2018, 35 specimens with no PCR bands for the 3.5 kb target were observed, and the rest failed to yield a long enough target for downstream sequencing. This report describes a significant technical improvement beyond previous efforts ([@ref005]) to more reliably amplify the 3.5 kb long rDNA target and increase the PCR yield for the crude, unpurified DNA extracts of single nematodes by utilizing proofreading DNA polymerase in an optimized solution. This is important because it is impractical in a nematode diagnostic laboratory to efficiently produce very clean DNA with a kit from only one or a few specimens.

Commonly used *Taq* DNA polymerase lacks proofreading ability, which limits the length of the amplicon, usually up to 2.9 kb ([@ref001]; [@ref015]). It has been demonstrated that long template DNA could be amplified successfully by adding a thermal proofreading DNA polymerase with 3' to 5' exonuclease activity to a *Taq* PCR system ([@ref002]; [@ref006]). As a result, many PCR amplification systems have been developed and made commercially available by blending a *Taq* polymerase and a thermal proofreading DNA polymerase supplied with a specially optimized PCR buffer. Two *Taq*-based blend systems, TaKaRa Ex *Taq*® DNA Polymerase (a blend of TaKaRa *Taq*® DNA Polymerase and an unspecified proofreading DNA polymerase) and PicoMaxx™ High Fidelity PCR System (a blend of *Taq*2000™ DNA polymerase, cloned *Pfu* DNA polymerase and ArchaeMaxx® polymerase enhancing factor) were selected and tested in this study.

Materials and methods {#sec1}
=====================

Live *Litylenchus* specimens were isolated from the banding lesions of American beech leaves with BLD as described in [Table 1](#tbl1){ref-type="table"}, after the leaves were dissected, and followed by water extraction. Some of the specimens were also imaged as vouchers for morphological and morphometrical analysis. The preparation of the crude and unpurified genomic DNA from a live single *Litylenchus* and the visualization, cleanup and direct DNA sequencing, including sequencing primers, of the PCR products were performed by using the procedures described in previous studies ([@ref005]).

###### 

*Litylenchus crenatae* specimens from American beech trees (*Fagus grandifolia*) with BLD tested in this study.

![](jofnem-52-016-t001)

  Specimens                                                                                   Locality                               Part   Session
  ------------------------------------------------------------------------------------------- -------------------------------------- ------ -----------------------
  104H78, 104H81, 104H82, 104H83, 104H84, 104H85, 104H86, 104H87, 104H88, 104H89 and 104H90   Lake County, Ohio                      Leaf   Fall (November, 2017)
  104J54, 104J55, 104J56 and 104J57                                                           Cuyahoga County, Ohio                  Leaf   Summer (May, 2018)
  104K17, 104K18, 104K19 and 104K20                                                           The Holden Arboretum, Kirtland, Ohio   Leaf   Summer (August, 2018)
  104K25, 104K26, 104K27, 104K28, 104K29, 104K30 and 104K31                                   Potter County, Pennsylvania            Leaf   Summer (August, 2018)
  104K37, 104K38 and 104K39                                                                   Crawford County, Pennsylvania          Leaf   Summer (August, 2018)
  104N95, 104N96 and 104N97                                                                   The Holden Arboretum, Kirtland, Ohio   Bud    Spring (March, 2019)

Either the 3.5 kb long segment or the 1.7 or 1.9 kb medium segment ribosomal amplifications by PCR with Dream*Taq*™ Hot Start DNA polymerase system (Dream*Taq*™, Thermo Fisher Scientific, Waltham, MA) were performed by using the procedures, including primer sets, 18S-CL-F3 and 28S-CL-R for the 3.5 kb ribosomal loci, 18S-CL-F3 and 18S-CL-R7 for the 18 S locus (1.7 kb) and ITS-CL-F2 and 28S-CL-R for the ITS-28S (D1D2D3) loci (1.9 kb) described in the previous study ([@ref004]) unless otherwise noted.

Assembling PCR buffer and parameterizing thermal cycling conditions in the following amplifications with different DNA polymerases were performed according to each respective manufacturers' guidance. Treatment components are summarized in [Table 2](#tbl2){ref-type="table"}, and cycling conditions in [Tables 3](#tbl3){ref-type="table"} and [4](#tbl4){ref-type="table"}.

###### 

PCR components and setup.

![](jofnem-52-016-t002)

                                       Platinum™ *Taq* (10 units/μl)   *Taq*2000™ (5 units/μl)   Dream*Taq*™ (5 units/μl)   TaKaRa Ex *Taq*™ (5 units/μl) or combined with Dream*Taq*™ (5 units/μl)   PicoMaxx™ System (5 units/μl) or combined with Dream*Taq*™ (5 units/μl)   *pfu* DNA polymerase (2.5 units/μl) or combined with Dream*Taq*™ (5 units/μl)   Herculase® II Fusion DNA polymerase   Phusion™ High-Fidelity DNA Polymerase (2 units/μl)   *Pwo* DNA polymerase (5 units/μl) or combined with Dream*Taq*™ (5 units/μl)
  ------------------------------------ ------------------------------- ------------------------- -------------------------- ------------------------------------------------------------------------- ------------------------------------------------------------------------- ------------------------------------------------------------------------------- ------------------------------------- ---------------------------------------------------- -----------------------------------------------------------------------------
  Water (μl)                                                                                                                                                                                                                                                                                                                                                                                                                                               Mixture A: 7.6
  Water (μl)                           15.375                          16                        16.375/16.25               15.875 or 15.75                                                           17.3 or 17.175                                                            17.05/17.55 or 16.925/17.425                                                    16                                    14.5                                                 Mixture B: 9.875 (or 9.75)
  10 or 5x proprietary buffer (μl)     2.5                             2.5                       2.5                        2.5                                                                       2.5                                                                       2.5                                                                             5                                     5                                                    Mixture A: 2.5
  50 mM MgCl~2~ (μl)                   1                               0.25                                                                                                                                                                                                                                                                                                                                                                                
  100 mM dNTP (25 mM each) (μl)                                                                                             0.2                                                                       0.2                                                                       0.25                                                                                                                                                                       Mixture B: 0.4
  10 mM dNTP (2.5 mM each) (μl)                                                                                             2                                                                                                                                                                                                                                                                         0.5                                                  
  8 mM dNTP (2 mM each) (μl)           2.5                             2.5                       2.5                                                                                                                                                                                                                                                                                                                                                       
  10 μm Forward primer (μl)            0.75                            0.75                      0.75                       1.25                                                                      1.25                                                                      1.25                                                                            0.625                                 1.25                                                 Mixture B: 1.25
  10 μm Reverse primer (μl)            0.75                            0.75                      0.75                       1.25                                                                      1.25                                                                      1.25                                                                            0.625                                 1.25                                                 Mixture B: 1.25
  DMSO                                                                                                                                                                                                                                                                                                                                                                                                0.25                                                 
  DNA template (μl)                    2                               2                         2                          2                                                                         2                                                                         2                                                                               2                                     2                                                    Mixture B: 2
  Proprietary DNA polymerase(s) (μl)   0.125                           0.25                      0.125/0.25                 0.125 or plus Dream*Taq*™: 0.125                                          0.5 or plus Dream*Taq*™: 0.125                                            0.75/0.25 or plus Dream*Taq*™: 0.125                                            0.5                                   0.25                                                 Mixture A: 0.125 or plus Dream*Taq*™: 0.125
  Total reaction volume (μl)           25                              25                        25                         25                                                                        25                                                                        25                                                                              25                                    25                                                   12.5 each mixture

###### 

PCR cycling conditions.

![](jofnem-52-016-t003)

                             Platinum™ *Taq*   *Taq*2000™                   Dream*Taq*™       TaKaRa Ex *Taq*™ or combined with Dream*Taq*™   PicoMaxx™ System or combined with Dream*Taq*™                                                                                              
  -------------------------- ----------------- ---------------------------- ----------------- ----------------------------------------------- ----------------------------------------------- ---------------------------- ----------------- ------------------------- ----------------- ----------------------------
  1\. Initial denaturation   95°C for 3 min    Sep 1: 1 cycle               95°C for 3 min    Step 1: 1 cycle                                 95°C for 3 min                                  Step 1: 1 cycle              98°C for 30 sec   Step 1: 1 cycle           95°C for 2 min    Step 1: 1 cycle
  2\. Denaturation           95°C for 30 sec   Step 2, 3 and 4: 36 cycles   95°C for 30 sec   Step 2, 3 and 4: 36 cycles                      95°C for 30 sec                                 Step 2, 3 and 4: 36 cycles   98°C for 10 sec   Step 2 and 4: 36 cycles   95°C for 30 sec   Step 2, 3 and 4: 36 cycles
  3\. Annealing              50°C for 45 sec                                50°C for 45 sec                                                   50°C for 45 sec                                                                                                          55°C for 45 sec   
  4\. Extension              72°C for 3 min                                 72°C for 3 min                                                    72°C for 3 min                                                               68°C for 5 min                              72°C for 5 min    
  5\. Final extension        72°C for 7 min    Step 5: 1 cycle              72°C for 7 min    Step 5: 1 cycle                                 72°C for 7 min                                  Step 5: 1 cycle              72°C for 7 min    Step 5: 1 cycle           72°C for 7 min    Step 5: 1 cycle

###### 

PCR cycling conditions.

![](jofnem-52-016-t004)

  No. Step                   *pfu* or combined with Dream*Taq*™   Herculase® II                Phusion™                *Pwo* or combined with Dream*Taq*™                                                                          
  -------------------------- ------------------------------------ ---------------------------- ----------------------- ------------------------------------ ----------------------- ---------------------------- ----------------- ----------------------------
  1\. Initial denaturation   95°C for 2 min                       Step 1: 1 cycle              95°C for 2 min          Step 1: 1 cycle                      95°C for 2 min          Step 1: 1 cycle              95°C for 2 min    Step 1: 1 cycle
  2\. Denaturation           95°C for 30 sec                      Step 2, 3 and 4: 36 cycles   95°C for 20 sec         Step 2, 3 and 4: 36 cycles           95°C for 20 sec         Step 2, 3 and 4: 36 cycles   95°C for 30 sec   Step 2, 3 and 4: 36 cycles
  3\. Annealling             55°C for 45 sec                                                   55°C for 20 sec                                              55°C for 20 sec                                      57°C for 45 sec   
  4\. Extension              72°C for 5 min                                                    72°C for 2 min 15 sec                                        72°C for 2 min 15 sec                                72°C for 5 min    
  5\. Final extension        72°C for 7 min                       Step 5: 1 cycle              72°C for 7 min          Step 5: 1 cycle                      72°C for 7 min          Step 5: 1 cycle              72°C for 7 min    Step 5: 1 cycle

Platinum™ *Taq* DNA polymerase {#sec1-1}
------------------------------

Each PCR amplification with Platinum™ *Taq* DNA Polymerase (Platinum™ *Taq*) (Thermo Fisher Scientific, Waltham, MA) was carried out in a 25 μl of mixture containing Platinum™ *Taq* (10 units/μl) 0.125 μl, 10X PCR Buffer Mg 2.5 μl, MgCl~2~ (50 mM) 1 μl, dNTP (2.0 mM each) 2.5 μl, Template DNA 2 μl, forward primer (10 μm) 0.75 μl and reverse primer (10 μm) 0.75 μl for either primer set 18S-CL-F3 and 28S-CL-R or ITS-CL-F2 and 28S-CL-R, and molecular biology grade water (Sigma-Aldrich, St Louis, MO) 15.375 μl. The thermal cycling program was one cycle of 95°C for 3 min; 36 cycles of 95°C for 30 sec, 50°C for 45 sec, 72°C for 3 min; and final extension at 72°C for 7 min.

*Taq*2000™ DNA polymerase {#sec1-2}
-------------------------

Each PCR amplification with *Taq*2000™ DNA Polymerase (Agilent, Santa Clara, CA) was carried out in a 25 μl mixture containing *Taq*2000™ (5 units/μl) 0.25 μl, 10X PCR Buffer 2.5 μl, MgCl~2~ (50 mM) 0.25 μl, dNTP (2.0 mM each) 2.5 μl, Template DNA 2 μl, both forward primer (10 μm) 0.75 μl and reverse primer (10 μm) 0.75 μl for either primer set 18S-CL-F3 and 28S-CL-R or ITS-CL-F2 and 28S-CL-R, and molecular biology grade water (Sigma-Aldrich, St Louis, MO) 16 μl. The thermal cycling program was one cycle of 95°C for 3 min; 36 cycles of 95°C for 30 sec, 50°C for 45 sec, 72°C for 3 min; and final extension at 72°C for 7 min.

TaKaRa Ex *Taq*™ DNA polymerase or combined with Dream*Taq*™ {#sec1-3}
------------------------------------------------------------

Each PCR amplification with TaKaRa Ex *Taq*™ DNA Polymerase (Takara Bio USA, Inc., Mountain View, CA) alone or combined with Dream*Taq*™ was carried out in a 25 μl of mixture containing TaKaRa Ex *Taq*™ (5 units/μl) 0.125 μl (or plus Dream*Taq*™ (5 units/μl) 0.125 μl), 10X Ex *Taq* Buffer 2.5 μl, dNTP (2.5 mM each) 2 μl, Template DNA 2 μl, forward primer 18S-CL-F3 (10 μm) 1.25 μl, reverse primer 28S-CL-R (10 μm) 1.25 μl, and molecular biology grade water (Sigma-Aldrich, St Louis, MO) 15.875 μl (or 15.75 μl). The thermal cycling program was: one cycle of 98°C for 30 sec; 36 cycles of 98°C for 10 sec, 68°C for 5 min; and final extension at 72°C for 7 min.

PicoMaxx™ High Fidelity PCR System alone or combined with Dream*Taq*™ {#sec1-4}
---------------------------------------------------------------------

Each PCR amplification with PicoMaxx™ High Fidelity PCR System (PicoMaxx™ System) (Agilent, Santa Clara, CA) alone or combined with Dream*Taq*™ was carried out in a 25 μl of mixture containing PicoMaxx™ high fidelity PCR system (PicoMaxx™ (5 units/μl)) 0.5 μl (or plus Dream*Taq*™ (5 units/μl) 0.125 μl), 10× PicoMaxx™ reaction buffer (PicoMaxx™ buffer) 2.5 μl, dNTP (25 mM each) 0.2 μl, Template DNA 2 μl, forward primer 18S-CL-F3 (10 μm) 1.25 μl, reverse primer 28S-CL-R (10 μm) 1.25 μl, and molecular biology grade water (Sigma-Aldrich, St Louis, MO) 17.3 μl (or 17.175 μl). The thermal cycling program was one cycle of 95°C for 2 min; 36 cycles of 95°C for 30 sec, 55°C for 45 sec, 72°C for 5 min; and final extension at 72°C for 7 min.

*pfu* DNA polymerase alone or combined with Dream*Taq*™: {#sec1-5}
--------------------------------------------------------

Each PCR amplification with *pfu* DNA polymerase (Agilent, Santa Clara, CA) alone or combined with Dream*Taq*™ was carried out in a 25 μl of mixture containing *pfu* (2.5 units/μl) 0.75 μl (or plus Dream*Taq*™ (5 units/μl) 0.125 μl), 10× *Pfu* reaction buffer, 10× PicoMaxx™ buffer, or 10× Dream*Taq*™ buffer 2.5 μl, dNTP (25 mM each) 0.2 μl, Template DNA 2 μl, forward primer 18S-CL-F3 (10 μm) 1.25 μl, reverse primer 28S-CL-R (10 μm) 1.25 μl, and molecular biology grade water (Sigma-Aldrich, St Louis, MO) 16.85 μl (or 16.725 μl). The thermal cycling program was one cycle of 95°C for 2 min; 36 cycles of 95°C for 30 sec, 55°C for 45 sec, 72°C for 5 min; and final extension at 72°C for 7 min.

*Pwo* DNA polymerase alone or combined with Dream*Taq*™ {#sec1-6}
-------------------------------------------------------

Each PCR amplification with *Pwo* DNA polymerase (Sigma-Aldrich, St Louis, MO) alone or combined with Dream*Taq*™ was carried out in a 25 μl final volume consisting of two mixtures: 12.5 μl of mixture A containing *Pwo* (5 units/μl) 0.125 μl (or plus Dream*Taq* (5 units/μl) 0.125 μl), 10× *Pwo* reaction buffer or 10× PicoMaxx™ buffer 2.5 μl, and molecular biology grade water (Sigma-Aldrich, St Louis, MO) 9.875 μl (or 9.75 μl); 12.5 μl of mixture B containing dNTP (25 mM each) 0.4 μl, template DNA 2 μl, forward primer 18S-CL-F3 (10 μm) 1.25 μl, reverse primer 28S-CL-R (10 μm) 1.25 μl. The thermal cycling program was one cycle of 95°C for 2 min; 36 cycles of 95°C for 30 sec, 57°C for 45 sec, 72°C for 5 min; and final extension at 72°C for 7 min.

Herculase® II Fusion DNA polymerase {#sec1-7}
-----------------------------------

Each PCR amplification with Herculase® II Fusion DNA polymerase (Agilent, Santa Clara, CA) was carried out in a 25 μl of mixture containing Herculase® II Fusion DNA polymerase 0.5 μl, 5× reaction buffer 5 μl, dNTP (25 mM each) 0.25 μl, Template DNA 2 μl, forward primer 18S-CL-F3 (10 μm) 0.625 μl, reverse primer 28S-CL-R (10 μm) 0.625 μl, and molecular biology grade water (Sigma-Aldrich, St Louis, MO) 16 μl. The thermal cycling program was: one cycle of 95°C for 2 min; 36 cycles of 95°C for 20 sec, 55°C for 20 sec, 72°C for 2 min 15 sec; and final extension at 72°C for 7 min.

Phusion™ High-Fidelity DNA polymerase {#sec1-8}
-------------------------------------

Each PCR amplification with Phusion™ High-Fidelity DNA Polymerase (Thermo Fisher Scientific, Waltham, MA) was carried out in a 25 μl of mixture containing Phusion™ High-Fidelity DNA Polymerase (2 units/μl) 0.25 μl, 5× reaction buffer 5 μl, dNTP (2.5 mM each) 0.5 μl, Template DNA 2 μl, forward primer 18S-CL-F3 (10 μm) 1.25 μl, reverse primer 28S-CL-R (10 μm) 1.25 μl, DMSO 0.25 μl, and molecular biology grade water (Sigma-Aldrich, St Louis, MO) 14.5 μl. The thermal cycling program was: one cycle of 95°C for 2 min; 36 cycles of 95°C for 20 sec, 55°C for 20 sec, 72°C for 2 min 15 sec; and final extension at 72°C for 7 min.

Results {#sec2}
=======

A summary of the PCR evaluations below based on specificity, efficiency and fidelity is given in [Table 5](#tbl5){ref-type="table"} for individual polymerase systems, and in [Table 6](#tbl6){ref-type="table"} for combined polymerase systems. [Figure 1](#fg1){ref-type="fig"} shows that the successful 3.5 kb long segment PCR amplifications by the 18S-CL-F3 and 28S-CL-R primer set and the Dream*Taq*™ system were carried out in 10 out of 11 Fall specimens. The direct sequencing for the three loci (3.5 kb) was also conducted successfully in all specimens, except for 104H89 and 104H90 with low PCR yields that were good for sequencing only one or two loci. The 3.5 kb rDNA sequences generated for the specimens, 104H82 ( MN525396) and 104H83 (MN525397) were submitted to GenBank. This result shows that Dream*Taq*™ had the ability to amplify the 3.5 kb target in most Fall specimens within the size limit by *Taq* DNA polymerase up to 3 to 4 kb on amplicon ([@ref008]; [@ref010]). However, failures (no yield for the 3.5 kb target) were observed in most Summer specimens ([Fig. 2A](#fg2){ref-type="fig"}, [Fig. 3A](#fg3){ref-type="fig"}, [Fig. 4A](#fg4){ref-type="fig"}). One possibility for this failure was amplicon size limitation associated with Dream*Taq*™ in these less mature Summer specimens. In order to address this issue, two medium segment PCR amplifications were carried out with Dream*Taq*™ and two primers sets, 18S-CL-F3/18S-CL-R7and ITS-CL-F2/28S-CL-R, which amplify the 18 S locus (1.7 kb), and ITS and 28 S loci (1.9 kb) within the 3.5 kb target, respectively. The amplifications showed that Dream*Taq*™ can amplify both medium 1.7 kb and 1.9 kb fragments with high yield ([Fig. 2B, 2C](#fg2 fg2){ref-type="fig"}), but not the 3.5 kb long targets ([Fig. 2A](#fg2){ref-type="fig"}) in these Summer specimens. This indicates that the amplification failure of the 3.5 kb long segment PCR in these Summer specimens is due to the size limitation of Dream*Taq*™ polymerase.

###### 

Summary of PCR performance of Individual DNA polymerases (systems) tested in this study.

![](jofnem-52-016-t005)

                     Platinum™ *Taq*          *Taq*2000™                           Dream*Taq*™                                             TaKaRa Ex *Taq*™    PicoMaxx™ System    *pfu*             *Pwo*             Herculase® II   Phusion™
  ------------------ ------------------------ ------------------------------------ ------------------------------------------------------- ------------------- ------------------- ----------------- ----------------- --------------- -----------
  Spring specimens   3.5 kb: X; 1.9 kb: √/X   3.5 kb: X; 1.9 kb: √√√√/X            3.5 kb: X; 1.9 kb: √√√√                                 na                  na                  na                na                na              na
  Summer specimens   na                       3.5 kb: X (DNS); 1.9 kb: √√√ (DNS)   3.5 kb: X or X/√ (DNS); 1.7Kb: √√√√/X; 1.9 kb: √√√√/X   3.5 kb: √√/X or X   3.5 kb: √√/X or X   3.5 kb: X (DNS)   3.5 kb: X (DNS)   3.5 kb: X       3.5 kb: X
  Fall specimens     na                       na                                   3.5 kb: √√√/X; 1.9 kb: NA                               na                  na                  na                na                na              na

**Notes:** DNS, data not shown. The middle segments, 1.7 and 1.9 kb were not tested in all specimens, unless otherwise noted. X: An unsuccessful PCR amplification. It was defined practically as: weak or no target PCR bands (yields) on the Lonza gels. For example, weak target PCR bands shown Lane 1 and 2 in [Figure 7B](#fg7){ref-type="fig"}, which could not provide sufficient templates for downstream direct DNA sequencing. √: A successful PCR amplification. It was defined practically based on the observations from our routine direct DNA sequencing as: the amount of resulting target amplicon in the 25 μl of PCR reaction is good for at least 6 sequencing reactions (√) in downstream direct DNA sequencing, for example, the target PCR band shown on the Lonza gel on lane 11, in [Figure 1](#fg1){ref-type="fig"} is good for at least 6 sequencing reactions (√), while each of the strong target PCR bands shown on the Lonza gel on lane 1 to 7 and 9 in [Figure 1](#fg1){ref-type="fig"} is good for at least 18 sequencing reactions (√√√). /X: In a test or repeating tests, most PCR amplifications were successful and only one or few were unsuccessful. /√: In a test or repeating tests, most PCR amplifications were unsuccessful and only one or few were successful

![Long range ribosomal PCR Amplifications of the 3.5 kb target from Summer specimens with both Dream*Taq*™ and *Pfu* in manufacturer's PCR buffers. M: DNA markers; 1: 104K29; 2: 104K30; 3: 104K31; NC: negative control, respectively. A: Dream*Taq*™ PCR buffer; B: *Pfu* PCR buffer.](jofnem-52-016-g007){#fg7}

###### 

Summary of PCR performance of blended DNA polymerases (systems) tested in this study.

![](jofnem-52-016-t006)

                     TaKaRa Ex *Taq*™ combined with Dream*Taq*™ in TaKaRa Ex buffer   PicoMaxx™ System combined with Dream*Taq*™ in PicoMaxx™ buffer   Dream*Taq*™ in PicoMaxx™ buffer   *pfu* in PicoMaxx™ buffer   *Pfu* combined with Dream*Taq*™ in PicoMaxx™ buffer   *pfu* combined with Dream*Taq*™ in Dream*Taq*™ buffer   *pfu* combined with Dream*Taq*™ in *pfu* buffer   *Pwo* in PicoMaxx™ buffer   *Pwo* combined with Dream*Taq*™ in *Pwo* buffer   *Pwo* combined with Dream*Taq*™ in PicoMaxx buffer
  ------------------ ---------------------------------------------------------------- ---------------------------------------------------------------- --------------------------------- --------------------------- ----------------------------------------------------- ------------------------------------------------------- ------------------------------------------------- --------------------------- ------------------------------------------------- ----------------------------------------------------
  Spring specimens   na                                                               na                                                               na                                na                          na                                                    na                                                      na                                                na                          na                                                na
  Summer specimens   3.5 kb: X                                                        3.5 kb: √√√/X                                                    3.5 kb: √/X or X                  3.5 kb: X                   3.5 kb: √√√√ or √√                                    3.5 kb: X                                               3.5 kb: X                                         3.5 kb: X                   3.5 kb: X (DNS)                                   3.5 kb: √/X
  Fall specimens     na                                                               na                                                               na                                na                          na                                                    na                                                      na                                                na                          na                                                na

**Note:** See the notes in [Table 5](#tbl5){ref-type="table"}.

![Long range ribosomal PCR Amplifications of the 3.5 kb target from Fall specimens with Dream*Taq*™. M: DNA markers; 1: 104H78; 2: 104H81; 3: 104H82; 4: 104H83; 5: 104H84; 6: 104H85; 7: 104H86; 8: 104H87; 9: 104H88; 10: 104H89; 11: 104H90; NC: negative control. 1-7: Female; 8-11: Male.](jofnem-52-016-g001){#fg1}

![Long range ribosomal PCR Amplifications of the 3.5 kb target from Summer specimens with TaKaRa Ex *Taq*® system. M: DNA markers; 1: 104J54; 2: 104J55; 3: 104J58; 4: 104J59; NC: negative control, respectively. A: Dream*Taq*™; B: 18 S locus (1.7 kb) by Dream*Taq*™, C: ITS and 28 S loci (1.9 kb) by Dream*Taq*™; D: TaKaRa Ex *Taq*® system.](jofnem-52-016-g002){#fg2}

![Long range ribosomal PCR Amplifications of the 3.5 kb target from Summer specimens with PicoMaxx™ High Fidelity PCR System. M: DNA markers; 1: 104K17; 2: 104K18; 3: 104K19; 4: 104K20; NC: negative control, respectively. A: Dream*Taq*™; B: PicoMaxx™ High Fidelity PCR System.](jofnem-52-016-g003){#fg3}

![Long range ribosomal PCR Amplifications of the 3.5 kb target from Summer specimens with PicoMaxx™ High Fidelity PCR System. M: DNA markers; 1: 104K25; 2: 104K26; 3: 104K27; 4: 104K28; 5: 104K29; 6: 104K30; 7: 104K31; NC: negative control, respectively. A: Dream*Taq*™; B: PicoMaxx™ High Fidelity PCR System.](jofnem-52-016-g004){#fg4}

Both TaKaRa *Taq*® and PicoMaxx™ systems can amplify the 3.5 kb target in some of the Summer specimens in which the Dream*Taq*™ failed (compare [Fig. 2A](#fg2){ref-type="fig"} with [2D](#fg2){ref-type="fig"} and [Fig. 3A](#fg3){ref-type="fig"} with [3B](#fg3){ref-type="fig"}). However, they also failed to amplify the 3.5 kb target in other Summer specimens ([Fig. 4B](#fg4){ref-type="fig"}; [Fig. 9A](#fg9){ref-type="fig"} (Lanes 5, 6, 7)). In order to establish a system to amplify the 3.5 kb target regardless of the variations of specimens, Dream*Taq*™ and PicoMaxx™ were combined to test if both work together to overcome this difficulty during the long segment PCR. In [Figure 5A, 5B](#fg5 fg5){ref-type="fig"}, Dream*Taq*™ demonstrated again its ability to amplify both 1.7 kb and 1.9 kb medium segment fragments within the 3.5 kb target in the difficult specimens. [Figure 5C](#fg5){ref-type="fig"} shows the robust amplifications of the 3.5 kb target for these specimens by the combination of Dream*Taq*™ and the PicoMaxx™ System, which suggests it is the proofreading ability by *Pfu* in PicoMaxx™ that greatly facilitates Dream*Taq*™. In order to elucidate the synergy between the two, reconstituting Dream*Taq*™ and the *Pfu* used in the PicoMaxx™ System was conducted. In the presence of the PicoMaxx™ buffer for these difficult specimens ([Fig. 6](#fg6){ref-type="fig"}), the Dream*Taq*™ alone barely amplified the 3.5 kb target (Lanes 1, 2, 3, [Fig. 6](#fg6){ref-type="fig"}). The proofreading *Pfu* by itself failed to amplify the product (Lanes 5, 6, 7, [Fig. 6](#fg6){ref-type="fig"}), but combining the Dream*Taq*™ and the *Pfu* delivered a robust amplification (Lanes 9, 10, 11, [Fig. 6](#fg6){ref-type="fig"}). We tested whether the combination works in the presence of either Dream*Taq*™ buffer or *Pfu* buffer. However, neither of them could facilitate the combination ([Fig. 7A, 7B](#fg7 fg7){ref-type="fig"}). This suggests that a long segment PCR may not be achieved by simply blending a *Taq* with a proofreading DNA polymerase, but the PCR buffer must be taken into account as well. In this system (Lanes 9, 10, 11, [Fig. 6](#fg6){ref-type="fig"}), the three proprietary components, Dream*Taq*™, *Pfu* and PicoMaxx™ buffer must be purchased separately, which is not economical. Therefore, the combination of Dream*Taq*™ and PicoMaxx™ High Fidelity PCR System (*Taq, Pfu* and buffer) seen in [Figure 5C](#fg5){ref-type="fig"} is the preferable option to address difficult specimens.

![PCR performance of TaKaRa Ex *Taq*® system and PicoMaxx™ High Fidelity PCR System. M: DNA markers; 1 and 5: 104K37; 2 and 6: 104K38; 3 and 7: 104K39; 4 and 8: 104K40. A: 1, 2, 3 and 4: TaKaRa Ex *Taq*® system; 5, 6, 7 and 8: PicoMaxx™ High Fidelity PCR System; B: 1, 2, 3 and 4: TaKaRa Ex *Taq*® system and Dream*Taq*™; 5, 6, 7 and 8: PicoMaxx™ High Fidelity PCR System. NC: negative control, respectively.](jofnem-52-016-g009){#fg9}

![Long range ribosomal PCR Amplifications of the 3.5 kb target from Summer specimens with Dream*Taq*™ and PicoMaxx™ High Fidelity PCR System. M: DNA markers; 1: 104K25; 2: 104K26; 3: 104K27; 4: 104K28; 5: 104K29; 6: 104K30; 7: 104K31; NC: negative control, respectively. A: 18 S locus (1.7 kb) by Dream*Taq*™, B: ITS and 28 S loci (1.9 kb) by Dream*Taq*™; C: Dream*Taq*™ and PicoMaxx™ High Fidelity PCR System combined.](jofnem-52-016-g005){#fg5}

![Long range ribosomal PCR Amplifications of the 3.5 kb target from Summer specimens with Dream*Taq*™ or/and *Pfu* in PicoMaxx™ buffer. M: DNA markers; 1, 2, 3 and 4: Dream*Taq*™; 5, 6, 7 and 8: *Pfu*; 9, 10, 11and 12: Dream*Taq*™ and *Pfu* combined; 1, 5 and 9: 104K29; 2, 6 and 10: 104K30; 3, 7 and 11: 104K31; 4, 8 and 12: negative control (NC), respectively.](jofnem-52-016-g006){#fg6}

*Pwo* (derived from *Pyrococcus woesei*), another proofreading DNA polymerase, was tested in line with the *Pfu* in PicoMaxx™ buffer. [Figure 8](#fg8){ref-type="fig"} shows that in the presence of the PicoMaxx™ buffer, both combinations (Lanes 1, 2, 3, 4, 5, 6 in [Fig. 8B](#fg8){ref-type="fig"}) are better than either *Pwo* or Dream*Taq*™ alone (Lanes 1, 2, 3, 4, 5, 6 in [Fig. 8A](#fg8){ref-type="fig"}), and the combination with *Pfu* performed better than the combination with *Pwo* ([Fig. 8B](#fg8){ref-type="fig"}). The presence of either Dream*Taq*™ buffer or *Pwo* buffer was also evaluated for the combination of Dream*Taq*™ and *Pwo* in a different specimen from beech buds collected in the spring of 2019 (Spring specimens). No significant amplifications of the 3.5 kb target were seen in the presence of either buffer (data not shown). This confirms again that PCR buffer is another key to the success of the Dream*Taq*™ and *Pfu* or *Pwo* combination.

![PCR performance of *Pfu* and *Pwo* in PicoMaxx™ buffer. M: DNA markers; 1 and 4: 104K37; 2 and 5: 104K38; 3 and 6: 104K39. A: 1, 2 and 3: Dream*Taq*™; 4, 5 and 6: *Pwo* (0.125 μl per reaction). B: 1, 2 and 3: Dream*Taq*™ and *Pfu*; 4, 5 and 6: Dream*Taq*™ and *Pwo* (0.125 μl per reaction). NC: negative control, respectively. Note: final concentration of *Pfu* in each reaction was aligned with *Pwo* and Dream*Taq*™ in 0.625 units.](jofnem-52-016-g008){#fg8}

The comparison between TaKaRa Ex *Taq*® system and PicoMaxx™ system was also performed. [Figure 9A](#fg9){ref-type="fig"} shows that both PicoMaxx and TaKaRa Ex *Taq*® systems failed to amplify the 3.5 kb target, but the PicoMaxx™ system gave Dream*Taq*™ dramatic leverage over the TaKaRa Ex *Taq*® system ([Fig. 9B](#fg9){ref-type="fig"}), and again the combination of Dream*Taq*™ and the PicoMaxx™ System demonstrated its robust long segment PCR amplification in the difficult specimens.

Fusion DNA polymerase is an engineered fusion of a proofreading polymerase and a processivity-enhancing domain ([@ref011]) and offers tremendous advantages over traditional *Taq* with high fidelity, robust amplification in low abundance, high GC, and other difficult targets, short extension times (1.0 kb/10-15 sec) and ability to amplify long target (\>20 kb) (both Agilent and Thermo Fisher Scientific web sites). Herculase® II Fusion DNA polymerase and Phusion™ High-Fidelity DNA Polymerase were tested. [Figure 10](#fg10){ref-type="fig"} shows both could not produce any 3.5 kb target bands except for the smear band by the Herculase® II Fusion DNA polymerase.

![PCR performance of Herculase® II Fusion DNA polymerase and Phusion™ High-Fidelity DNA Polymerase. M: DNA markers; 1 and 5: 104K37; 2 and 6: 104K38; 3 and 7: 104K39; 4 and 8: 104K40. 1, 2, 3 and 4: Herculase® II Fusion DNA polymerase; 5, 6, 7 and 8: Phusion™ High Fidelity PCR System; NC: negative control, respectively.](jofnem-52-016-g010){#fg10}

The PCR performances of *Taq*2000™, which is one of the components of the PicoMaxx™ system, Platinum™ *Taq* and Dream*Taq*™ were also compared in Spring specimens. In the presence of their own buffers, both the long segment PCR for the 3.5 kb target and the medium range PCR for the 1.9 kb target were carried out. In the long segment PCR amplifications, all of the three *Taqs* failed to amplify the 3.5 kb target ([Fig. 11A](#fg11){ref-type="fig"}). In the medium segment PCR amplifications, the Platinum™ *Taq* weakly amplified the 1.9 kb target (Lanes 5, 6 in [Fig. 11B](#fg11){ref-type="fig"}), the *Taq*2000™ was able to amplify two specimens successfully (Lanes 2, 3 in [Fig. 11B](#fg11){ref-type="fig"}), and the Dream*Taq*™ outperformed either the Platinum™ *Taq* or *Taq*2000™ in all three specimens (Lanes 7, 8, 9 in [Fig. 11B](#fg11){ref-type="fig"}). This indicates that Dream*Taq*™ has better sensitivity in this situation than either the Platinum™ *Taq* or *Taq*2000™. It also further explains why combining the PicoMaxx™ system (PicoMaxx™ and PicoMaxx™ buffer) and Dream*Taq*™ can successfully amplify the 3.5 kb target in the specimens where both Dream*Taq*™ and PicoMaxx™ systems failed separately.

![PCR performance of *Taq*2000™, Platinum™ *Taq* and Dream*Taq*™. M: DNA markers; 1, 4 and 7: 104N95; 2, 5 and 8: 104N96; 3, 6 and 9: 104N97. 1, 2, 3 and NC by *Taq*2000™; 4, 5, 6 and NC by Platinum™ *Taq*; 7, 8, 9 and NC by Dream*Taq*™, NC: negative control, respectively. A: 3.5 kb target; B: 1.9 kb ITS and 28 S target. Note: final concentration of either *Taq*2000™ or Dream*Taq*™ in each reaction was aligned with Platinum™ *Taq* in 1.25 units.](jofnem-52-016-g011){#fg11}

The 3.5 kb targets amplified by the *Taq*-based blend systems, TaKaRa Ex *Taq*® DNA Polymerase in the specimen 104J58 (OH), PicoMaxx™ High Fidelity PCR System in the Summer Specimen 104K17 (OH); by the combination of Dream*Taq*™ and PicoMaxx™ High Fidelity PCR System in the Summer specimens, 104K25 (Potter County, PA) and 104K37 (Crawford County, PA) were sequenced and the resulting rDNA sequences (ITS and 28 S loci) were deposited in GenBank with the accession numbers, 104H82, MN525396; 104H83, MN525397; 104J58 MN525398; 104K17, MN525399; 104k25, MN525400; 104K37, MN525401, respectively. Multiple alignments of these sequences above with the 3.5 kb rDNA (MK292137 and MK292138) of the Ohio *Litylenchus* specimens in the previous study ([@ref004]) reveal that the ITS and 28 S (D1D2D3) sequences of the Pennsylvania specimens are 100% identical to the Ohio specimens.

Discussion {#sec3}
==========

The molecular taxonomic identifications performed in this study not only confirmed that the nematodes discovered in BLD leaves from Ohio and Pennsylvanian are the same species of *Litylenchus crenatae mccannii*, but they also demonstrated a technical improvement to achieve consistent amplification of the 3.5 kb ribosomal PCR product through long segment PCR amplification using sometimes variable quality crude genomic DNA extracts as template.

We observed that most Fall specimens were mature and not very active, but with highly developed reproductive systems containing many germ cells. In contrast, most Summer specimens were young, motile adults with a poorly developed reproductive system. The cuticle is the first barrier for proteinase K to lyse in a nematode which is relatively tough and resistant to environmental forces in young adults, but loose, wrinkled, permeable and susceptible to environmental insults in older adults ([@ref014]; [@ref007]; Herndon et al., 2017). These differences mean the Fall Specimen nematode cuticles are more easily broken down by proteinase K to release more genomic DNA. This is especially favorable for long DNA fragments (i.e. larger than 3.5 kb) which have more unlysed debris and impurities than fragments found in younger Summer specimens. Thus, both the quantity of the 3.5 kb target template and the debris and impurities in the crude unpurified genomic DNA lysates may vary from session to session and specimen to specimen. This phenomenon was demonstrated by the successful amplification of the 3.5 kb target by Dream*Taq*™ in Fall specimens ([Fig. 1](#fg1){ref-type="fig"}), but not in the Summer specimens ([Figs. 1A](#fg1){ref-type="fig"} and [2A](#fg2){ref-type="fig"}). The debris or impurities in the incomplete genomic DNA lysates from Summer specimens may interfere with the PCR extension of the 3.5 kb target by increasing the probability of incorporating wrong nucleotides and consequently increasing the size limitation associated with Dream*Taq*™ and eventually failing the 3.5 kb long segment PCR, but not the medium segment PCR amplification ([Fig. 2A, 2B, 2C](#fg2 fg2 fg2){ref-type="fig"}). This failure can be prevented by a proofreading DNA polymerase (either TaKaRa Ex *Taq*® system or the PicoMaxx™ system) in these Summer specimens ([Figs. 2D](#fg2){ref-type="fig"} and [3B](#fg3){ref-type="fig"}).

When both Dream*Taq*™ and these *Taq*-based blend systems failed ([Fig. 4](#fg4){ref-type="fig"}), both the low quantity of the 3.5 kb long fragments and the debris and impurities in the input DNA were the apparent causes. These double failures were prevented by employing both Dream*Taq*™ and the PicoMaxx™ system ([Fig. 5C](#fg5){ref-type="fig"}). Per the vendor's information, Dream*Taq*™ DNA Polymerase could amplify a target from as low as 3 pg of purified human genomic DNA, and provided higher sensitivity compared to six other *Taq* DNA polymerases, including TaKaRa *Taq*® DNA Polymerase (a component of the TaKaRa Ex *Taq*® system). Dream*Taq*™ also demonstrated its higher sensitivity than either *Taq*2000™ or Platinum™ *Taq* ([Fig. 11B](#fg11){ref-type="fig"}). The failures of the PicoMaxx™ system were caused by the low sensitivity of its *Taq*2000™ DNA polymerase and were reversed by adding Dream*Taq*™ ([Figs. 5C](#fg5){ref-type="fig"} and [9B](#fg9){ref-type="fig"}) because of its high sensitivity. The direct synergy between Dream*Taq*™ and proofreading *Pfu*, the key component in the PicoMaxx™ system, is further confirmed in [Figure 6](#fg6){ref-type="fig"}. In the combination of Dream*Taq*™ and the PicoMaxx™ system, Dream*Taq*™ and proofreading *Pfu* worked synergistically only in the presence of PicoMaxx™ buffer ([Fig. 6](#fg6){ref-type="fig"} Lanes 9, 10, 11, [Fig. 7A, 7B](#fg7 fg7){ref-type="fig"}). Both *Pfu* and *Pwo* were also compared directly in this study ([Fig. 8](#fg8){ref-type="fig"}). The synergy with Dream*Taq*™ was not supported by either of their own buffers, but PicoMaxx™ buffer allowed *Pfu* to perform more robustly than *Pwo*. Therefore, the PCR buffer is also required for successful synergy between Dream*Taq*™ and *Pfu* or *Pwo*. Tests in two Fusion DNA polymerases suggest Fusion DNA polymerases may not be suitable for crude unpurified genomic DNA in low quantity and quality although they have multiple advantages over traditional *Taq* ([Fig. 10](#fg10){ref-type="fig"}).

Taken together, the size limit to the 3.5 kb target by *Taq*, the low quantity of the 3.5 kb target template and the debris and impurities in the crude and unpurified genomic DNA lysates are three primary factors responsible for the failures of the 3.5 kb long PCR amplification in the Summer specimens. Establishing the combination of Dream*Taq*™ and the PicoMaxx™ system in this study well addressed the issues above for the 3.5 kb long segment ribosomal PCR amplification by combining the sensitivity of Dream*Taq*™, the proofreading of *Pfu* and the sensitivity and robustness of PicoMaxx™ buffer. In this study long segment ribosomal PCR amplification in various *Litylenchus* specimens has been achieved by this technical improvement. Successful long ribosomal PCR by this improvement was also conducted for other taxa, *Ditylenchus* sp. (Tylenchida), *Pristionchus* sp. (Rhabditida) and *Prodorylaimus* sp. (Dorylaimida) when their specimens were difficult to amplify with the one primer set and Dream*Taq*™ (data not shown). This improvement provides high fidelity, sensitivity and yield with minimum optimization of reaction and cycling conditions. It should not be limited to long segment PCR amplification only, and could be considered for short range PCR with forensic or ancient DNA, single copy nuclear gene PCR or where improved proofreading can rescue mismatches that take place between the 3' primer termini and its target templates.

The authors thank David McCann, Ohio State Department of Agriculture, Reynoldsburg, OH; David Burke, The Holden Arboretum, Kirtland, OH; Tracey Olson and Thomas Hall, PA Department of Agriculture, Harrisburg, PA for nematode specimens. Mention of a trade name or commercial product in this publication is solely for the purpose of providing specific information and does not imply recommendation or endorsement by the US Department of Agriculture. USDA is an equal opportunity provider and employer.

[^1]: This paper was edited by: Zafar Ahmad
